Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0650

0.0%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: pincus who wrote (12130)	6/28/2013 2:16:20 PM
From: NTTG	Read Replies (1) of 13111

Odd......FDA is getting a lot done with other drugs, why so 'disorganized' (or disinterested) when it comes to PV-10? Maybe the confusion is not with the FDA? This is definitely a drug that will need a long shelf life, for all the anticipated approval delays and low commercial use it will get in the west...of course, given poor access to refrigeration in China, that could be a plus...some day - no time table = continued delays for MM PIII approval - simple narrow approval = stage III only; the hope that off label use will build their market is a poor commercial business plan Emphasis on HCC in the Pacific Rim sets the company $ for development back to PI stage...where is progress on PH-10? Diminished emphasis on BTD is probably a good reality check Sounds like popcorn impresses the group a lot more than RB does...the problem here is there are no knowledgable parters involved with shepherding this company through next steps......bet next years refreshments are even thriftier than this years..... and now you know why SP continues to decline...smoke screen...they are working all the angles, for sure

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next